Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Endocrinology

Diabetic ketoacidosis

Diabetic ketoacidosis

Diabetic ketoacidosis (DKA) may be a complication of existing type 1 diabetes mellitus or be the first presentation, accounting for around 6% of cases. Rarely, under conditions of extreme stress, patients with type 2 diabetes mellitus may also develop DKA.

Whilst DKA remains a serious condition, mortality rates have decreased from 8% to under 1% in the past 20 years.

Pathophysiology
  • DKA is caused by uncontrolled lipolysis (not proteolysis) which results in an excess of free fatty acids that are ultimately converted to ketone bodies
  • Absolute or relative insulin deficiency, together with increased counter-regulatory hormones (especially glucagon), drives hepatic gluconeogenesis and glycogenolysis → hyperglycaemia
  • Hyperglycaemia exceeds the renal threshold → glycosuria → osmotic diuresis
    • Leads to loss of water and electrolytes (including potassium), explaining the dehydration, tachycardia, and hypotension seen clinically
  • Uncontrolled lipolysis releases free fatty acids → hepatic ketogenesis
    • Produces 3-beta-hydroxybutyrate, acetoacetate, and acetone (responsible for fruity breath)
  • Accumulation of ketones → metabolic acidosis
    • Drives Kussmaul respiration and contributes to nausea, vomiting, and abdominal pain
  • Potassium imbalance:
    • Total body potassium is depleted due to urinary losses from osmotic diuresis and vomiting
    • Serum potassium may initially be normal or raised due to acidosis and insulin deficiency shifting potassium out of cells
    • Potassium levels often fall rapidly with treatment (especially insulin), creating a risk of arrhythmias

Pathophysiology of diabetic ketoacidosis

The most common precipitating factors of DKA are infection, missed insulin doses and myocardial infarction.

Features
  • abdominal pain
  • polyuria, polydipsia, dehydration
  • Kussmaul respiration (deep hyperventilation)
  • Acetone-smelling breath ('pear drops' smell)

Diagnostic criteria

American Diabetes Association (2009)Joint British Diabetes Societies (2013)
Key points
  • glucose > 13.8 mmol/l
  • pH < 7.30
  • serum bicarbonate <18 mmol/l
  • anion gap > 10
  • ketonaemia
Key points
  • glucose > 11 mmol/l or known diabetes mellitus
  • pH < 7.3
  • bicarbonate < 15 mmol/l
  • ketones > 3 mmol/l or urine ketones ++ on dipstick

Management

Main principles of management
  • fluid replacement
    • most patients with DKA are deplete around 5-8 litres
    • isotonic saline is used initially, even if the patient is severely acidotic
    • please see an example fluid regime below.
  • insulin
    • an intravenous infusion should be started at 0.1 unit/kg/hour
    • once blood glucose is < 14 mmol/l an infusion of 10% dextrose should be started at 125 mls/hr in addition to the 0.9% sodium chloride regime
  • correction of electrolyte disturbance
    • serum potassium is often high on admission despite total body potassium being low
    • this often falls quickly following treatment with insulin resulting in hypokalaemia
    • potassium may therefore need to be added to the replacement fluids
    • if the rate of potassium infusion is greater than 20 mmol/hour then cardiac monitoring may be required
  • long-acting insulin should be continued, short-acting insulin should be stopped

JBDS example of fluid replacement regime for patient with a systolic BP on admission 90mmHg and over

FluidVolume
0.9% sodium chloride 1L1000ml over 1st hour
0.9% sodium chloride 1L with potassium chloride1000ml over next 2 hours
0.9% sodium chloride 1L with potassium chloride1000ml over next 2 hours
0.9% sodium chloride 1L with potassium chloride1000ml over next 4 hours
0.9% sodium chloride 1L with potassium chloride1000ml over next 4 hours
0.9% sodium chloride 1L with potassium chloride1000ml over next 6 hours

Please note that slower infusion may be indicated in young adults (aged 18-25 years) as they are at greater risk of cerebral oedema.

JBDS potassium guidelines

Potassium level in first 24 hours (mmol/L)Potassium replacement in mmol/L of infusion solution
Over 5.5Nil
3.5-5.540
Below 3.5Senior review as additional potassium needs to be given

JBDS Single-page treatment pathway for DKA
JBDS Example intravenous insulin prescription
JBDS Example fluid protocol
JBDS Example management chart for the management of DKA: 0-80 minutes
JBDS Example management chart for the management of DKA: 60 minutes - 6 hours

Resolution

DKA resolution is defined as:
  • pH >7.3 and
  • blood ketones < 0.6 mmol/L and
  • bicarbonate > 15.0mmol/L

Further points
  • both the ketonaemia and acidosis should have been resolved within 24 hours. If this hasn't happened the patient requires senior review from an endocrinologist
  • if the above criteria are met and the patient is eating and drinking switch to subcutaneous insulin
  • the patient should be reviewed by the diabetes specialist nurse prior to discharge

Complications

Complications may occur from DKA itself or the treatment:
  • gastric stasis
  • thromboembolism
  • arrhythmias secondary to hyperkalaemia/iatrogenic hypokalaemia
  • iatrogenic due to incorrect fluid therapy: cerebral oedema*, hypokalaemia, hypoglycaemia
  • acute respiratory distress syndrome
  • acute kidney injury

* children/young adults are particularly vulnerable to cerebral oedema following fluid resuscitation in DKA and often need 1:1 nursing to monitor neuro-observations, headache, irritability, visual disturbance, focal neurology etc. It usually occurs 4-12 hours following commencement of treatment but can present at any time. If there is any suspicion a CT head and senior review should be sought
+PassMedicine Notes

Diabetic ketoacidosis (DKA) may be a complication of existing type 1 diabetes mellitus or be the first presentation, accounting for around 6% of cases. Rarely, under conditions of extreme stress, patients with type 2 diabetes mellitus may also develop DKA.

Whilst DKA remains a serious condition, mortality rates have decreased from 8% to under 1% in the past 20 years.

Pathophysiology
  • DKA is caused by uncontrolled lipolysis (not proteolysis) which results in an excess of free fatty acids that are ultimately converted to ketone bodies
  • Absolute or relative insulin deficiency, together with increased counter-regulatory hormones (especially glucagon), drives hepatic gluconeogenesis and glycogenolysis → hyperglycaemia
  • Hyperglycaemia exceeds the renal threshold → glycosuria → osmotic diuresis
    • Leads to loss of water and electrolytes (including potassium), explaining the dehydration, tachycardia, and hypotension seen clinically
  • Uncontrolled lipolysis releases free fatty acids → hepatic ketogenesis
    • Produces 3-beta-hydroxybutyrate, acetoacetate, and acetone (responsible for fruity breath)
  • Accumulation of ketones → metabolic acidosis
    • Drives Kussmaul respiration and contributes to nausea, vomiting, and abdominal pain
  • Potassium imbalance:
    • Total body potassium is depleted due to urinary losses from osmotic diuresis and vomiting
    • Serum potassium may initially be normal or raised due to acidosis and insulin deficiency shifting potassium out of cells
    • Potassium levels often fall rapidly with treatment (especially insulin), creating a risk of arrhythmias

The most common precipitating factors of DKA are infection, missed insulin doses and myocardial infarction.

Features
  • abdominal pain
  • polyuria, polydipsia, dehydration
  • Kussmaul respiration (deep hyperventilation)
  • Acetone-smelling breath ('pear drops' smell)

Diagnostic criteria

American Diabetes Association (2009) _ Joint British Diabetes Societies (2013)| Key points
  • glucose > 13.8 mmol/l
  • pH < 7.30
  • serum bicarbonate 10
  • ketonaemia_
Key points
  • glucose > 11 mmol/l or known diabetes mellitus
  • pH < 7.3
  • bicarbonate < 15 mmol/l
  • ketones > 3 mmol/l or urine ketones ++ on dipstick |

Management

Main principles of management
  • fluid replacement
    • most patients with DKA are deplete around 5-8 litres
    • isotonic saline is used initially, even if the patient is severely acidotic
    • please see an example fluid regime below.
  • insulin
    • an intravenous infusion should be started at 0.1 unit/kg/hour
    • once blood glucose is < 14 mmol/l an infusion of 10% dextrose should be started at 125 mls/hr in addition to the 0.9% sodium chloride regime
  • correction of electrolyte disturbance
    • serum potassium is often high on admission despite total body potassium being low
    • this often falls quickly following treatment with insulin resulting in hypokalaemia
    • potassium may therefore need to be added to the replacement fluids
    • if the rate of potassium infusion is greater than 20 mmol/hour then cardiac monitoring may be required
  • long-acting insulin should be continued, short-acting insulin should be stopped

JBDS example of fluid replacement regime for patient with a systolic BP on admission 90mmHg and over

Fluid _ Volume | 0.9% sodium chloride 1L _ 1000ml over 1st hour | 0.9% sodium chloride 1L with potassium chloride _ 1000ml over next 2 hours | 0.9% sodium chloride 1L with potassium chloride _ 1000ml over next 2 hours | 0.9% sodium chloride 1L with potassium chloride _ 1000ml over next 4 hours | 0.9% sodium chloride 1L with potassium chloride _ 1000ml over next 4 hours | 0.9% sodium chloride 1L with potassium chloride _ 1000ml over next 6 hours |

Please note that slower infusion may be indicated in young adults (aged 18-25 years) as they are at greater risk of cerebral oedema.

JBDS potassium guidelines

Potassium level in first 24 hours (mmol/L) _ Potassium replacement in mmol/L of infusion solution| Over 5.5 _Nil| 3.5-5.5 _ 40| Below 3.5 _Senior review as additional potassium needs to be given|

Resolution

DKA resolution is defined as:
  • pH >7.3 and
  • blood ketones < 0.6 mmol/L and
  • bicarbonate > 15.0mmol/L
Further points
  • both the ketonaemia and acidosis should have been resolved within 24 hours. If this hasn't happened the patient requires senior review from an endocrinologist
  • if the above criteria are met and the patient is eating and drinking switch to subcutaneous insulin
  • the patient should be reviewed by the diabetes specialist nurse prior to discharge

Complications

Complications may occur from DKA itself or the treatment:
  • gastric stasis
  • thromboembolism
  • arrhythmias secondary to hyperkalaemia/iatrogenic hypokalaemia
  • iatrogenic due to incorrect fluid therapy: cerebral oedema*, hypokalaemia, hypoglycaemia
  • acute respiratory distress syndrome
  • acute kidney injury

* children/young adults are particularly vulnerable to cerebral oedema following fluid resuscitation in DKA and often need 1:1 nursing to monitor neuro-observations, headache, irritability, visual disturbance, focal neurology etc. It usually occurs 4-12 hours following commencement of treatment but can present at any time. If there is any suspicion a CT head and senior review should be sought



Saved ✓

MEDIA